Similarly, pediatric CF patients have shown improvements in gut environment following CFTR modulator administration 116,119
On January 5, 2026, Novo Nordisk announced it had launched an oral tablet version of its injectable GLP-1 weight-loss medication, Wegovy (semaglutide)
To view or add a comment, sign in From life-saving biologics to everyday essentials, the integrity of the supply chain is the lifeline of clinical delivery and helping patients Yet, with global volatility and rising demand, many providers are finding their traditional models under immense strain
It is not intended for human consumption, therapeutic use, diagnosis, or veterinary use.